Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04575155 · ClinicalTrials.gov registry record · NA

Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management

A NA study, sponsored by Northwestern University.

Completed
Registry status
NA
Development phase
119
Enrollment target

NCT04575155: Completed NA study, sponsored by Northwestern University.

NCT04575155 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 119 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04575155, a NA study, has completed, sponsored by Northwestern University.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target

Study Summary

The investigators will link community pharmacy and primary care practices via a shared electronic health record to improve medication therapy management for older patients taking complex prescription (Rx) regimens. The Technology-Enabled Alliance for Medication Therapy Management (TEAM) intervention will link a major, national community pharmacy chain (Walgreens) to primary care practices (Access Community Health Network) via a shared electronic health record (EHR) platform (Epic, Verona WI). Through shared access to patients' medical records, pharmacists can perform comprehensive medication therapy management services, document and communicate patients' Rx challenges for review and action by primary care providers. The aims of this investigation are to: 1. Evaluate the fidelity and efficacy of the TEAM intervention to promote healthcare provider counseling, medication reconciliation, and safe regimen use among adults taking complex Rx regimens. 2. Explore patient, healthcare provider (pharmacist, prescriber), community pharmacy and/or primary care practice barriers to implementation. 3. Determine the costs of the TEAM intervention from both a community pharmacy and primary care practice perspective.

Primary Outcome

Number of medications discrepancies is measured as the sum of omissions (medications listed in the EHR but the patient reported not taking) and commissions (patient reported taking medications not in the EHR) at baseline and 2 months post baseline. Count of discrepancies at the 2 months follow-up is modeled using a multivariate Poisson regression model, with number of prescribed medications as an offset variable. The model is controlled for confounding variables and the number of medication disc

Interventions

  • BEHAVIORAL TEAM Strategy

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2020-10-23
Est. Completion 2022-10-31
Phase NA
Northwestern University

1,209 total trials

What the finished NCT04575155 record still lists

NCT04575155 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).

The record links to 0 conditions, and to 1 intervention - of which TEAM Strategy is the first listed.

NCT04575155 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04575155 about?

NCT04575155 is a clinical study titled "Development & Pilot of the Technology-Enabled Alliance for Medication Therapy Management". The investigators will link community pharmacy and primary care practices via a shared electronic health record to improve medication therapy management for older patients taking complex prescription (Rx) regimens. The Technology-Enabled Alliance for Medication Therapy Management (TEAM) intervention...

What is the current status of trial NCT04575155?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2020-10-23. Estimated completion is 2022-10-31.

What interventions are being tested in trial NCT04575155?

The interventions under investigation include: TEAM Strategy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04575155?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04575155's enrollment target sits among peer trials

119 803rd of 2000 higher than 1,198 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04575155, the US trial registry maintained by the National Library of Medicine. NCT04575155 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.